Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A3DSV01
Thu, 05.09.2024
Cantourage Group SE
Company Name:
Cantourage Group SE
ISIN:
DE000A3DSV01
Reason for the research:
Recommendation:
Buy
from:
05.09.2024
Target price:
EUR 10.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
FY24 guidance issued, growth to remain stellar
Topic: Cantourage issued a bullish FY24 sales growth guid [ … ]
Wed, 03.07.2024
Cantourage Group SE
Not for release, publication or distribution, directly or indirectly, in or into the United States of America, Australia, Canada or Japan or any other jurisdiction in which such release, publication or distribution would be unlawful. The important notes at the end of this announcement need to be observed.
Cantourage Group SE: Strong growth cont [ … ]
Tue, 06.02.2024
Cantourage Group SE
Cannabis legalization around the corner
Topic: With the approval of the 'Cannabis Act', which is now expected to
take place at the beginning of April, Germany is seen to take a big leap
forward in regards to legalizing cannabis. This should translate into a
significant tailwind for players such as Cantourage.
As per consistent and reliable Ge [ … ]
Mon, 20.11.2023
Cantourage Group SE
Not for publication or distribution, directly or indirectly, in or into the United States of America, Australia, Canada or Japan or any other jurisdiction in which such publication or distribution would be unlawful. The important notices at the end of this press release should be observed.
Cantourage Group SE records significant revenue growth in [ … ]
Wed, 25.10.2023
Cantourage Group SE
Not for publication or distribution, directly or indirectly, in or into the United States of America, Australia, Canada or Japan or any other jurisdiction in which such publication or distribution would be unlawful. The important notices at the end of this press release should be observed.
Cantourage Group SE: NuWays confirms "Buy" recommendation
[ … ]
Tue, 24.10.2023
Cantourage Group SE
Not for publication or distribution, directly or indirectly, in or into the United States of America, Australia, Canada or Japan or any other jurisdiction in which such publication or distribution would be unlawful. The important notices at the end of this press release should be observed.
Cantourage Group SE launches a range of high-THC medicin [ … ]
Fri, 20.10.2023
Cantourage Group SE
Not for publication or distribution, directly or indirectly, in or into the United States of America, Australia, Canada or Japan or any other jurisdiction in which such publication or distribution would be unlawful. The important notices at the end of this press release should be observed.
Montega AG includes Cantourage Group SE in its coverage [ … ]
Mon, 25.09.2023
Cantourage Group SE
Not for release or distribution, directly or indirectly, in or into the United States of America, Australia, Canada or Japan or any other jurisdiction where such release or distribution would be unlawful. Please see the important notice at the end of this announcement.
Cantourage Group SE: Cantourage shortlisted for European Small and Mid-Cap Awar [ … ]
Fri, 01.09.2023
Cantourage Group SE
Telecan°: Germany’s largest medical cannabis company launches online platform for cannabis on prescription
Berlin-based Cantourage launches Telecan°, its own telemedicine platform for medical cannabis
With Telecan°, patients can receive advice on the possibilities of cannabis therapy and obtain cannabis prescriptions in an uncomplicated manner
[ … ]
Thu, 10.08.2023
Cantourage Group SE
Not for release or distribution, directly or indirectly, in or into the United States of America, Australia, Canada or Japan or any other jurisdiction where such release or distribution would be unlawful. Please see the important notice at the end of this announcement.Cantourage Group SE welcomes SUMO Cannabis: New partner focuses on particularly r [ … ]